EARLY DRUG DEVELOPMENT: OPTIMIZING THE VALUE OF YOUR COMPOUND FOR BETTER PARTNERSHIP OR LICENSING DEALS
Wednesday, March 29th, 2017
09:30 - 17:00
BioM Biotech Cluster Development GmbH
Am Klopferspitz 19a (IZB West II), 82152 Martinsried


View full agenda and topics here.

SPEAKERS:
  • Berthold Hinzen, Vice President, Business Development and Licensing
    Bayer AG
  • Joachim Scholp, Global Head Research Beyond Borders Clinica
    Boehringer Ingelheim Pharma GmbH & Co. KG
  • Justin J. Devine, Chief Medical Officer
    Synexa Life Sciences
  • Claudia Graeve, Vice President
    Health Advances LLC
  • Matthias Grossmann, Vice President & Principal Consultant
    PAREXEL International
  • Laura Iavarone, QCD Scientific Director, Quantitative Clinical Development
    PAREXEL International
To register, please complete the information below. A confirmation will be sent with details once your RSVP is processed.







By submitting this form, you consent to receive communications from PAREXEL.
Click here to customize your preferences or opt-out.

©2017 PAREXEL International Corp.
195 West Street Waltham, MA, 02451, USA • Tel: +1 781-487-9900
Privacy Policy | EU-US Privacy Shield Notice | Contact Us